43. Crossing the finishing line in biotech

<p>We talk a lot about beginnings on <em>Discovery Matters</em>, but what about actually getting biologic drugs to people? Once the biologic is produced, aseptic filling and hybrid glass and plastic vials help to protect the biologic drug and the patient.</p> <p>Join Dodi, Conor and their guests, Chris Weikart the Chief Scientist at SiO2 Material Science, and Ross Gold one of the founders of Cytiva's aseptic filling business, in the latest episode of <em>Discovery Matters</em>, talking about the end of the workflow.</p>